CANY
QDEL icon

Caxton Associates (New York)’s QuidelOrtho QDEL Stock Holding History

Caxton Associates (New York)’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,637
Closed -$256K – 632
2022
Q2 		$256K Buy
+2,637
New +$269K 0.02% 417
2020
Q4 		– Sell
-1,053
Closed -$231K – 292
2020
Q3 		$231K Sell
1,053
-2,952
-74% -$659K 0.02% 238
2020
Q2 		$896K Sell
4,005
-2,384
-37% -$374K 0.08% 74
2020
Q1 		$625K Buy
+6,389
New +$517K 0.11% 117
2018
Q3 		– Sell
-5,435
Closed -$361K – 518
2018
Q2 		$361K Buy
+5,435
New +$328K 0.02% 288

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Caxton Associates (New York)'s QDEL Position: Q3 2022 in Review

Caxton Associates (New York) sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 2,637 shares — an estimated $256K sold.

Caxton Associates (New York) first reported a position in QDEL in Q2 2018 and held it in 5 quarters. The position peaked at $896K in Q2 2020. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Caxton Associates (New York) reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,637 QuidelOrtho shares in Q3 2022, an estimated $256K.
  • Caxton Associates (New York) first reported a position in QuidelOrtho in Q2 2018 and held it in 5 quarters.
  • Caxton Associates (New York)'s QuidelOrtho position peaked at $896K in Q2 2020.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.